Full-Time

Software Engineer – New Grad

Posted on 9/17/2024

Genesis Therapeutics

Genesis Therapeutics

51-200 employees

AI-driven drug discovery for pharmaceuticals

AI & Machine Learning
Biotechnology

Entry

Burlingame, CA, USA

Hybrid position in Burlingame, CA.

Category
Backend Engineering
Full-Stack Engineering
Software Engineering

You match the following Genesis Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • A deep thinker who reasons from first principles, balances attention to detail with architectural thinking, and has an investigational curiosity to find the root cause of a problem
  • Comfortable working across all levels of the software stack, from front-end interfaces to backend features to managing infrastructure
  • Have experience writing production code and driving internship and school projects to completion
  • Interested in learning more about drug discovery and machine learning
Responsibilities
  • Build and expand on tools for visualizing molecules and proteins, analyzing machine learning models, and managing complex chemical workflows
  • Work closely with machine learning engineers and medicinal chemists to develop and productionize new computational methods for molecular property prediction
  • Help scale our data infrastructure to handle billions of datapoints and thousands of parallel deep learning and molecular dynamics jobs

Genesis Therapeutics focuses on accelerating the development of new medicines by using artificial intelligence in the drug discovery process. The company employs a method that combines 3D spatial graph modeling and advanced molecular simulation to identify potential drug candidates. This approach enables them to explore new chemical spaces and discover novel protein targets, which can lead to important new medicines. Unlike many competitors, Genesis Therapeutics operates on a business-to-business model, primarily serving other biotech and pharmaceutical companies, such as Eli Lilly, through strategic partnerships. Their goal is to create effective new drugs by leveraging their unique AI-driven platform and to generate revenue through upfront payments and potential future earnings based on the success of the drugs they help develop.

Company Stage

Series B

Total Funding

$272.5M

Headquarters

Burlingame, California

Founded

2019

Growth & Insights
Headcount

6 month growth

1%

1 year growth

2%

2 year growth

1%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with NVIDIA enhances GEMS platform for targeting undruggable diseases.
  • $224 million equity investment boosts research and development capabilities.
  • Recognition as a 'Fierce 15' company underscores AI's role in breakthrough therapeutics.

What critics are saying

  • Competition from AI-driven companies like Insilico Medicine and Exscientia is increasing.
  • Over-reliance on partnerships could lead to financial instability if drugs aren't successful.
  • Rapid AI advancements may render current models like GEMS obsolete without updates.

What makes Genesis Therapeutics unique

  • Genesis Therapeutics uses AI to accelerate drug discovery with 3D spatial graph modeling.
  • The GEMS platform integrates deep learning, molecular simulations, and generative AI for drug design.
  • Strategic partnerships with Eli Lilly and Gilead highlight Genesis' industry collaboration strength.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Competitive salary

Equity

Medical, dental, & vision insurance

401(k) program

INACTIVE